Joint Formulary & PAD

Copper sulfate - Copper deficiency

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Red
Formulations :
  • Infusion
Associated Icons :
Restrictions / Comments :
Important
Enteral supplementation resistant deficiency due to malabsorption

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Copper sulfate
Indication :
Copper deficiency
Group Name :
Keywords :
enteral supplementation resistant deficiency due to malabsorption
Brand Names Include :
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0

Other Indications

Below are listed other indications that Copper sulfate is used to treat.

  • No records returned.

Other Drugs

Below are listed other drugs that are used to treat Copper deficiency.

  • No records returned.

Committee Recommendations (1)

This drug has been included on the joint formulary having been agreed by the DTC of at least one Surrey Heartlands Acute Trust.

See “Formulary Status” to identify where this drug has been agreed for use.